In 1978, Schofield introduced the concept of a hematopoietic stem cell niche in the bone marrow 2 capable of harboring native HSCs (Schofield, 1978) . Since then, intensive research has revealed 3 its crucial role in self-renewal, apoptosis, differentiation, quiescence, migration and immune 4 privilege of HSCs (Morrison and Scadden, 2014) . The HSC niche is a complex structure in the HSPCs in the bone marrow niche has been a subject of considerable interest in recent times.
7
In our present day, animals are commonly used for the testing of emerging drugs. Apart from 1 8 ethical considerations, this practice contains many downsides. Among these are the unreliable 1 9
test results due to species-specific differences in rodent models. Concerning the bone marrow, bones support hematopoiesis in mice (Yu and Scadden, 2016) . It has been reported that less than isolated nucleated cells of the human bone marrow on a hydroxyapatite scaffold in a perfused 9 system for three weeks. Subsequently, HSPCs were successfully cultured in this scaffold for one 1 0
week (Di Maggio et al., 2011; Sharma et al., 2012; Walasek et al., 2012) . Concerning a bone various hematopoietic populations to differentiate into their respective progeny.
In a preceding publication, we presented a proof-of-principle of a novel in vitro bone marrow 1 8 model which utilizes a scaffold mimicking the structure and surface properties of the cancellous 1 9
bone microstructure, thus, facilitating unobstructed interaction between the bone marrow-derived 2 0
MSCs and umbilical cord-derived HSPCs (Sieber et al., 2018) . The whole model is placed in a 2 1 microfluidic device enabling the generation of different niches as well as the co-culture with 2 2 other in vitro organ models. In this publication, by among others providing Illumina prove the functionality and robustness of this versatile pure in vitro bone marrow model, thereby 1 exhibiting its vast potential. The here presented model demonstrates for the first time the 2 successful long-term culture of functional multipotent HSCs in a dynamic environment for at 3 least eight weeks. The model surpasses all previously presented 3D bone marrow models in 4 culturing time of HSCs as well as in mimicking the in vivo environment (Kim et al., 2015) .
5
Predestining it as a model for sophisticated in vitro drug testing, thus, serving as an alternative to 6 animal testing. 7 8
Results

9
In this bone marrow model, we rebuild this environment in a hydroxyapatite-coated zirconium 1 0 oxide scaffold with the intention of facilitating the long-term culture of primitive HSCs. The foundation for the successful culture of HSCs in the bone marrow model is laid by cavities could be observed in various places throughout the ceramic. These bridge structures were 1 also found in human bone marrow samples examined by our group (Fig. 1C and D) .
2 Subsequently, CD34 + HSPCs isolated from umbilical cord blood were cultured on the prepared 3 ceramics within the MOC over the course of four weeks. HSPCs were extracted from the ceramic 4 after 1, 2, 3 and 4 weeks of culture under dynamic conditions and stained for CD34 and CD38.
5
Although the percentage of CD34 + CD38 -HSPCs decreased over the time of culture, a substantial 6 proportion of the regained cells, on average 32.96%, retained their primitive phenotype after four 7 weeks of culture ( Fig. 1E ).
8
To assess the conserved differentiation ability of the long-term cultured HSCs, a CFU-GEMM 9 assay was conducted. Compared to freshly isolated HSPCs, the colony numbers were comparable 1 0 to the freshly isolated HSPCs after four weeks of culture ( Fig. 1F ). properties of individual primary cells with donor intrinsic expression intensities characterized by 1 7
donor-specific clustering ( Fig. 2A ). Comparative cluster analysis of regulated genes regulation and cytoskeleton rearrangement were overrepresented (Fig. 3A ). According to the 1 intensified cell-cell contact in 3D culture genes mediating focal adhesion, gap junction formation, 2 and ECM-receptor interaction were determined to be overrepresented within the set of 3 differentially expressed genes (Fig. 3A) . To assess the quality of cell division regulation upon niche, the expression of molecules known to be essential for HSC maintenance were determined.
1 5
The majority of the analyzed molecules are expressed by MSC independent of the cultivation 1 6 method with no significant regulation upon 3D culture ( Fig. 4 A-C). Only a very few genes like 1 7
thrombopoietin CASR or delta-like molecules (DLL) are very little or not expressed at all. In 1 8
reference to DESEQ2 analysis, only a small number of genes were differentially expressed.
1 9
BMP-2 and Angiopoietin-1 displayed elevated expression whereby molecules like JAG1 and 2 0 KITLG showed even decreased RNA levels upon ceramic cultivation Fig. 4 A and B ). During the culture of the HSPCs on the MOC, cells that appeared to be HSPCs were observed in 1 the medium reservoir, i.e., the culture compartment not occupied by the ceramic. To investigate if 2 the cells had started to differentiate after they had left the environment of the ceramic, the 3 ceramic and circulating HSPCs were analyzed separately.
4
Native HSCs (CD45RA -CD34 + CD38 -CD90 + ) resided more abundantly in the artificial bone 5 marrow niche in the ceramic compared to the circulation. After 2, 3 and 4 weeks of culture, a 6 significant difference between the two compartments could be detected (Fig. 5A) . The difference 7 was also apparent when looking at the absolute cell numbers, although only the difference after 8 three weeks of culture was significant ( Fig. 5D ). In line with these observations, more cells 9 expressing the myeloid marker CD45RA were found in the circulation. In percentage as well as 1 0 absolute cell numbers, a significant difference could be observed after three weeks of culture 1 1 ( Fig. 5B and E). Although there was no significant difference in the other weeks, a clear trend 1 2 was evident. The same applied for the expression of the erythroid marker CD36.
3
Having established that a significant difference between the cells extracted from the ceramic and 1 4 the circulation exists, a more extensive analysis of the subpopulation of differentiated HSPCs was 1 5 carried out. Due to a two-week stabilization phase, the cultures lasted for 3, 4 and 5 weeks. The 1 6 stabilization phase was introduced to generate a higher starting population. For the 1 7 characterization of the cells potentially differentiating in the neutrophil lineage, the occurrence of 1 8
GMPs, myeloblasts, myelocytes, and neutrophils was investigated. FACS analysis applying the 1 9
individual marker molecules CD34, CD38, CD45RA, CD36, CD15 and CD16 and their 2 0 combinations for the distinct differentiation stages were conducted. GMPs and myelocytes were 2 1 the cell types essentially found whereas myeloblasts and neutrophils were barely present in both 2 2 compartments, the ceramic and the circulation system ( Fig. 6 ). The bone marrow model is robust 3
The cultivation system is characterized by augmentation of HSC within the first weeks of culture.
4 Therefore, the option to harvest cells from the system during a running experiment for multiple 5 applications was assessed. Furthermore, a positive result opens up the possibility to continually 6 monitor various parameters in bone marrow safety studies without ending the experiment. After a 7 two-week stabilization phase, all, half or none of the HSPCs extracted from the circulation during 8 medium exchange were returned to the MOC. After this stabilization period, the culture ran for 9 an additional 1, 2 or 3 weeks.
0
Regarding the CD34 + CD38cells, more cells were found in the circulation compared to the 1 1 ceramic after three weeks of culture after complete cell reintroduction confirming the 1 2 accumulation of HSC in early culture phases. After week five, the percentage of CD34 + CD38 -1 3 cells appeared to be evenly distributed except for the 0% reintroduction group where a higher rate 1 4
was seen in the circulation. The impact of cell removal was undoubtedly visible but not 1 5 significant. Except for the cells extracted from the ceramic after five weeks of culture, a clear 1 6
gradation was observable between the three different groups (Fig. 7 ).
7
Native HSCs (CD45RA -CD34 + CD38 -CD90 + ) were more abundantly identified in the ceramic as 1 8
shown in Figure 5 and 7. An exception was the absolute cell number detected after five weeks of was higher than the 50% reintroduction group and comparable to the 100% reintroduction group 1 suggesting a renewal of the HSC subpopulation upon cell removal ( Fig. 7) . Transplantation of cells into irradiated immunocompromised mice is the gold standard assay to 1 8 determine the stem cell state of hematopoietic stem cells. It demonstrates that HSCs are still able 1 9
to long-term repopulate a vacant bone marrow niche and are therefore native stem cells.
0
The quantification of human CD45 expressing cells in the blood samples taken four, eight and 2 1 twelve weeks after the injection of 4 weeks in vitro cultured HSPCs into recipient mice revealed
an approximation of the values to the control of freshly isolated cells. No significant difference 1 was detectable between the two values 12 weeks post-injection ( Fig. 9 A-C). The same applied to 2 the B cell (CD45 + CD19 + ), monocyte (CD45 + CD14 + ) and NK cell (CD45 + CD56 + CD16 + ) 3 populations within human CD45 + cell compartment. The only exception was the occurrence of 4 human T cells (CD45 + CD3 + ) after 12 weeks which were significantly lower than the control 5 within the human cell subset (Fig. 9D ). All percentages, except for leukocytes, refer to the 6 CD45 + gate. human leukocytes in the blood had further increased, which especially applied to the number of T contribute to the niche biology since essential growth factors and other essential signaling After the addition of the CD34 + HSPCs isolated from umbilical cord blood, the bone marrow expression levels intrinsic to primary cells. Therefore, it is conceivable to apply the system for 1 5 questions of personalized issues regarding HSC maintenance.
6
Leaving the environment of the ceramic promotes differentiation 1 7
The significantly higher occurrence of native HSCs in the artificial in vitro bone marrow niche in smaller than in vivo (12.7%) (Greer, 1993) . A significant number of neutrophils was not 1 6 detectable. One reason might be a lack of G-CSF which is critical for neutrophil maturation. The 1 7
introduction of endothelial cells, which are known to secrete G-CSF, could solve this problem. The removal of cells during medium exchange did not have a significant impact on the bone Even though a significant difference in the T cell population measured after 12 weeks in the 1 7 mouse, no other significant differences were observed in comparison to the control. Thus, the 1 8 engraftment of the HSCs that were cultured for four weeks in the bone marrow model on the have vanished after this time (Doulatov et al., 2012; Pineault and Abu-khader, 2015) .
2
In a second experiment, HSCs were cultured for eight weeks in the bone marrow model on the primitive HSCs and its implementation on the MOC. In the first step, a suitable environment for 1 3 long-term HSC culture was generated. In the second step, HSPCs isolated from umbilical cord 1 4 blood were seeded in this bone marrow mimicking environment. It could be shown that HSCs 1 5 remained their native phenotype for at least eight weeks in dynamic culture conditions. 1 6
Furthermore, a significant deviation in the differentiation pattern was observed between HSPCs 1 7 residing in the circulation and in the ceramic in the MOC. Significantly more native HSCs were 1 8 present in the ceramic while significantly more differentiated HSPCs were identified in the 1 9
circulation. Also, granulopoiesis could be observed without the addition of further cytokines.
0
In conclusion, the here presented bone marrow model demonstrates for the first time the Germany) + 1% Penicillin-Streptomycin (P/S) (Biowest, France) and used until passage 7.
1 5 GmbH, Germany) were used as a scaffold for the 3D culture. The cylindrically shaped ceramics 3 are 5.8 mm in height and diameter. The pore size in the ceramic is the same as observed for the 4 human bone marrow. MSCs were seeded onto the scaffold in DMEM + 10% FCS + 1% P/S and 5 cultured for seven days. Subsequently, medium was changed to Stemspan-ACF + 25 ng/ml 6 FLT3-L + 10 ng/ml TPO + 1% P/S and 5,000 CD34 + CD38 -HSPCs were added and allowed to 7 adhere overnight in the incubator. The next morning, the ceramics were transferred to the MOC 8 for dynamic culture. For medium exchange, the medium was collected and centrifuged at 300 g 9 for 5 min. The supernatant was discarded, and the pellet resuspended in fresh medium and 1 0 transferred back onto the ceramic. The medium was exchanged every 2 to 3 days.
Isolation of HSPCs
1
In one experiment, ceramic and circulating HSPCs were analyzed separately, the ceramic was 1 2 transferred from the culture compartment to a 24-well plate well for extraction of HSPCs. The 1 3
remaining HSPCs in the MOC were defined as circulating cells.
4
In another experiment, after a two-week stabilization period, all, 50% or 0% of the HSPCs 1 5 extracted during medium exchange were returned to the MOC. For the 50% return, half the 1 6 medium was discarded before centrifugation. After centrifugation, the pellets were each 1 7 resuspended in fresh medium and pipetted back into the medium or ceramic reservoir, 1 8
respectively. For the 0% return, the whole medium cell suspension was discarded. The medium 1 9 was exchanged for the last time as described above two days prior cells were being analyzed. The multi-organ-chip is a microfluidic platform which was developed in our institute. It consists 2 2 of two separate independent circular channel systems. Each circuit is hosting two culture The seeded ceramic was placed in one of the two culture compartments of each circuit. Only the 1 7
outer compartments of the system were used for the ceramic while the inner served as medium PBS and afterward fixed in 4% PFA for three hours. The day before microscopy, samples were 1 dried using an ascending sequence. The samples were mounted on a support using silver before 2 being transferred to a vacuum chamber and sputter-coated with gold. The myeloid differentiation potential of the HSPCs extracted from the ceramic was assessed by In vivo application of HSC into immunodeficient mice 1 7
For in vivo application of HSC NOD.cg-Prkdc scid Il2rg tm1 Saug (NOG) mouse strain from 1 8
Taconic was used. Three-week-old NOG mice were irradiated with 1.5Gy at least 4h before HSC 1 9
application.
2 0 HSC samples for direct application without in vitro culture were thawed in high percentage Unpaired t-test was applied to the data sets, using GraphPad Prism software version 6.04 1 0
(GraphPad Software Inc., USA). P values smaller than or equal to 0.05 were considered 1 1 significant. The authors sincerely thank the Vivantes Hospital in Friedrichshain, Berlin for providing 1 4
umbilical cord blood samples and the Immanuel Hospital in Berlin for providing bone marrow 1 5
samples. We also thank Alexandra Lorenz for designing the bone marrow culture compartments. in vitro with comparable efficacy to freshly isolated cells. The Table is showing the mean number 1 4
of counted colonies of the CFU-GEMM assay performed with cells extracted after four weeks of 1 5 culture (n = 7) or with freshly isolated HSPCs from umbilical cord blood. proliferation. F  i  g  7  :  I  m  p  a  c  t  o  n  t  h  e  h  e  m  a  t  o  p  o  i  e  t  i  c  p  o  p  u  l  a  t  i  o  n  b  y  r  e  i  n  t  r  o  d  u  c  i  n  g  1  0  0  %  ,  5  0  %  o  r  0  %  o  f  c  e  l  l  s  d  u  r  i  n  g  1  m  e  d  i  u  m  e  x  c  h  a  n  g  e  d  e  m  o  n  s  t  r  a  t  e  s  t  h  e  r  o  b  u  s  t  n  e  s  s  o  f  t  h  e  s  y  s  t  e  m  .  2  (  A  -B  )  P  e  r  c  e  n  t  a  g  e  a  n  d  a  b  s  o  l  u  t  e  c  e  l  l  n  u  m  b  e  r  s  o  f  C  D  3  4  +  C  D  3  8  -c  e  l  l  s  a  n  d  (  C  -D  )  o  f  C  D  4  5  R  A  -C  D  3  4  +  C  D  3  8  - 
